New venture fund, chaired by Sir Richard Sykes, plans to raise up to $250m to invest in European life science, energy and software companies Source: FT.com - Pharmaceuticals
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,